Sign up to receive email updates, action alerts, health tips, promotions to support our work and more from EWG. You can opt-out at any time. [Privacy]


Hidden In Plain Sight

Trans Fat Hides in at Least a Quarter of Supermarket Foods


May 22, 2015

Hidden In Plain Sight: References

Aldai, N, de Renobales M, Barron LJR, Kramer JKG.  2013.  What are the trans fatty acids issues in foods after discontinuation of industrially produced trans fats?  Ruminant products, vegetable oils, and synthetic supplements.  Eur J Lipid Sci Technol. 115: 1378–1401.

Bendsen NT, Stender S, Szecsi PB, Pedersen SB, Basu S, Hellgren LI, Newman JW, Larsen TM, Haugaard SB, Astrup A.  2011.  Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women.  J Lipid Res.  52(10): 1821-8.

Brouwer IA, Wanders AJ, Katan MB.  2013.  Trans fatty acids and cardiovascular health: research completed?  Eur J Clin Nutr. 67(5): 541-7.

CDC (Centers for Disease Control and Prevention).  2013a.  Deaths: Leading Causes for 2010.  Available: [Accessed November 24, 2014].

CDC (Centers for Disease Control and Prevention).  2013b.  National Center for Health Statistics (US). Health, United States, 2012: With Special Feature on Emergency Care. Hyattsville (MD): National Center for Health Statistics (US).  Morbidity.  Available:!po=37.5000 [Accessed November 24, 2014].

CDC (Centers for Disease Control and Prevention).  2014.  Trans fat.  Available: [Accessed May 18, 2015]

De Greyt, WF, Kellens, MJ and Huyghebaert AD.  1999.  Effect of physical refining on selected minor components in vegetable oils.  Fett/Lipid.  101: 428–432.

Dietz WH, Scanlon KS. 2012. Eliminating the use of partially hydrogenated oil in food production and preparation. JAMA. 308(2): 143-4

Doell, Folmer D, Lee H, Honigfort M, Carberry S.  2012.  Updated estimate of trans fat intake by the US population.  Food Addit Contam Part A Chem Anal Control Expo Risk Assess.  29(6): 861-74.

European Food Safety Authority (EFSA).  2010.  EFSA Panel on Dietetic Products, Nutrition, and Allergies.  Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol.  EFSA Journal.  8(3): 1461

EWG (Environmental Working Group).  2015.  Food Scores.  Available: [Accessed May 18, 2015]

FDA (Food and Drug Administration).  2013a.  Tentative Determination Regarding Partially Hydrogenated Oils; Request for Comments and for Scientific Data and Information. Fed. Reg. Vol 78, No. 217: 67169 - 67175, November 8, 2013. Available: [Accessed Sept. 12, 2014]

FDA (Food and Drug Administration).  2013b.  Meeting Memorandum Between FDA CFSAN and GMA December 19 2013 re: FDA’s tentative determination regarding partially hydrogenated oils (PHOs).  Available:!documentDetail;D=FDA-2013-N-1317-0199 [Accessed December 9, 2014]

GMA (Grocery Manufacturers Association).  2013.  Partially Hydrogenated Oils in the Food Supply PowerPoint Presentation re Meeting Memorandum Between FDA/CFSAN and GMA December 19, 2013 re: FDA’s Tentative Determination Regarding Partially Hydrogenated Oils (PHOs).  Available:!documentDetail;D=FDA-2013-N-1317-0214  [Accessed December 9, 2014]

Hasenhuettl GL and Hartel RW.  2008.  Food Emulsifiers and Their Applications, 2nd edition.   Springer. 

Laake I, Pedersen JI, Selmer R, Kirkhus B, Lindman AS, Tverdal A, Veierød MB.  2012.  A prospective study of intake of trans-fatty acids from ruminant fat, partially hydrogenated vegetable oils, and marine oils and mortality from CVD.  Br J Nutr.  108(4): 743-54.

Kris-Etherton PM1, Lefevre M, Mensink RP, Petersen B, Fleming J, Flickinger BD.  2012.  Trans fatty acid intakes and food sources in the U.S. population: NHANES 1999-2002.  Lipids.  47(10): 931-40.

Micha R and Mozaffarian D.  2008.  Trans fatty acids: Effects on cardiometabolic health and implications for policy. Prostaglandins Leukot Essent Fatty Acids 2008, 79:147–152.

Motard-Bélanger A, Charest A, Grenier G, Paquin P, Chouinard Y, Lemieux S, Couture P, Lamarche B.  2008.  Study of the effect of trans fatty acids from ruminants on blood lipids and other risk factors for cardiovascular disease. Am J Clin Nutr.  87: 593–9.

Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC.  2006.  Trans fatty acids and cardiovascular disease. N Engl J Med, 354:1601–1613.

National Academy of Science.  2002.  Report Offers New Eating and Physical Activity Targets to Reduce Chronic Disease Risk.  Available: (Accessed April 21, 2015).

Oomen CM, Ocké MC, Feskens EJ, van Erp-Baart MA, Kok FJ, Kromhout D.  2001.  Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study.  Lancet.  357(9258): 746-51.

Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC.  2005.  Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses' health study.  Am J Epidemiol. 161(7): 672-9.

Sikorski ZE and Kolakowka A.  2003.  Chemical and Functional Properties of Food Lipids.  CRC Press.

Ratnayake NWM and Zehaluk C.  2005.  Trans Fatty Acids in Food and Their Labeling Regulations.  In Healthful Lipids. Akoh CC and Lai OM editors.  Available:

Tarrago-Trani MT, Phillips KM, Lemar LE, Holden JM.  2006.  New and existing oils and fats used in products with reduced trans-fatty acid content.  J Am Diet Assoc.  106(6): 867-80.

Teegala SM, Willett WC, Mozaffarian D.  2009.  Consumption and health effects of trans fatty acids: a review. Journal of AOAC International. 92:1250–1257.

USDA (U.S. Department of Agriculture). 2013. USDA National Nutrient Database for Standard Reference, Release 26. Agricultural Research Service Nutrient Data Laboratory. Available: [Accessed May 18, 2015]

WHO (World Health Organization). 2003. Diet, nutrition and the prevention of chronic diseases: Report of a Joint WHO/FAO Expert Consultation. WHO Technical Report Series, No. 916. Available: WHO_TRS_916.pdf [Accessed March 30, 2014].

WHO (World Health Organization).  2012.  A comprehensive global monitoring framework including indicators and a set of voluntary global targets for the prevention and control of noncommunicable diseases. Geneva.  Available: http://www.who. int/nmh/events/2012/discussion_paper3.pdf. [Accessed March 30, 2014].